• Journal of the Korean Orthopaedic Association
• /
• v.55 no.1
• /
• pp.54-61
• /
• 2020

Purpose: Brown tumor is a tumor-like disease that can occur as a linked disease of hyperparathyroidism which can causes osteoporosis, osteitis fibrosa cystica, pathologic fractures. Brown tumor has been reported as a case report, but there is no comprehensive report on the exact diagnosis and principle of management for osseous lesion. The purpose of this study is to report the treatment and results of osseous lesions through 5 cases. Materials and Methods: From February 2004 to May 2015, five cases of Brown tumor were diagnosed in Chosun University Hospital and Chonnam National University Hospital orthopedic department. Medical records and radiographs were reviewed retrospectively. Parathyroid tumors were surgically removed, and surgical treatment and observation were performed for orthopedic osseous lesions. Results: The mean length of the long axis of the symptomatic osseous lesion was 6.2 cm (4.5-9.0 cm). An average of 7.6 (range, 3 to 14) of high uptake osseous lesion showed in whole body bone scan. The absolute value, T-score and Z-score of the vertebrae and proximal femur were adequate for diagnosis of osteoporosis using dual energy X-ray absorptiometry bone mineral density at diagnosis and recovered to normal at the last follow-up. In laboratory tests, serum concentrations of total calcium, ionized calcium, inorganic phosphorus, serum alkaline phosphatase, and parathyroid hormone were helpful to diagnosis and normalized upon successful removal of parathyroid adenoma or cancer. Conclusion: For accurate diagnosis of Brown tumor, it should be accompanied by systemic examination as well as clinical symptoms, laboratory tests and radiologic examination for osseous lesions. And a good prognosis can be expected if the hyperparathyroidism is treated together with the comprehensive treatment of osseous lesions.

• Korean journal of communication and information
• /
• v.61
• /
• pp.5-27
• /
• 2013

Media coverage of depression, the mental disorder, is on the high rise following the soaring number of reported celebrity suicide. This study is an exploratory attempt to get a glance on how online news media are portraying depression. The content analysis results indicate that celebrity was the most cited source, outnumbering the others such as non-celebrity patients and experts. More than half of the sample attributed the cause of depression to socio-psychological factors. Medical consultation was the most reported means of treating depression among the sample, while over the half did not suggest any treatment methods at all. Overall, celebrity related news were less likely to talk about the cause and treatment methods. In addition, the more neuro-biological factors were designated as the main cause of depression in the articles, the more chances of treatment method of all kinds were brought up. The frame of human interest dominated a little less than half of the articles examined, and only few reported positive outcome or achievements after coping with depression.

• Journal of Yeungnam Medical Science
• /
• v.22 no.1
• /
• pp.1-12
• /
• 2005

Normal growth and development is of prime concern during childhood. The treatment of children with growth hormone deficiency has been revolutionized by growth hormone therapy. An improved height outcome with a final height within the target height range has been achieved. However, close follow-up with regular clinical and laboratory monitoring is essential for achieving the desirable height outcome. The theoretical unlimited supply of growth hormone has led to its wide spread use in a variety of disorders other than a growth hormone deficiency. Initially used in children with Turner syndrome, growth hormone is now used to treat chronic renal failure, an idiopathic short stature and intrauterine growth restrictions in addition to a wide array of newly emerging indications. This review summarizes the basics for a proper growth assessment, the differentiation of normal and abnormal growth causes of a short stature, and the indications for growth hormone treatment.

• Childhood Kidney Diseases
• /
• v.13 no.1
• /
• pp.14-20
• /
• 2009

Growth retardation is a common consequenc of chronic kidney disease (CKD) in childhood. Many recent clinical and experimental data indicate that growth failure in CKD is mainly due to a relative GH insensitivity and functional IGF-I deficiency. Glucocorticoids also glucocorticoids interfere with the integrity of the somatotropic hormone axis at various levels. Over the past 10 years, recombinant growth hormone (rhGH) has been used to help short children with chronic kidney disease. A GH dosage of 0.35 mg/kg/week (28 IU/$m^2$/week) appears efficient and safe. Some clinical trial data show that final height will be within the normal target height range when GH treatment is continued for many years without remarkable adverse events.

• Journal of the korean veterinary medical association
• /
• v.38 no.6
• /
• pp.549-558
• /
• 2002

3.5살짜리 래브라도 리트리버(Labrador Retriever)는 매일 처방되는 피질스테로이드제에 무반응으로 비계절적, 심한 소양증을 2년간 앓고 있는 병력을 갖고 있었다. 공기유래 알레르겐(알러젠; Allergens)들에 대한 시험관내 RAST1(Radioallergosorbent testing; 방사선 알레르기 흡착 시험법)에 양성으로 나타난 것을 기초로 한 면역요법(Immunotherapy)을 18개월 동안 시행했으나 성공적이지 않았다. 부신피질호르몬(Adrenocorticotropic Hormone, ACTH)자극 시험법은 이것이 본래 임상수의사에 의해 발생(Iatrogenic)된 것임을 예시하여준다. 피부 찰과물(Skin scrapings)을 검사한 결과 개 천공개선충(Sarcoptic mange)이라는 진단이 내려졌다. 이버맥틴(Ivermectin)치료효과와 피질스테로이드(Corticosteroid)의 투약중지에 대한 반응이 극적으로 나타났다. 10개월 추적기간(10-month follow-up period)동안에 이 질병은 재발되지 않았다. 이것은 비록 계절적인 알레르겐을 배제하기 위해 긴 기간동안 추적이 필요하였으나 개 천공개선충이 오히려 피질스테로이드요법에 대한 2차적인 것보다는 1차적인 질병이라는 것을 말해준다. 아토피의 진단을 위해 혈청학적 시험법의 이용이 논의되었다.

• Proceedings of the Plant Resources Society of Korea Conference
• /
• 2018.10a
• /
• pp.131-131
• /
• 2018

중국(中國) 장홍화(藏紅花)는 해발 1500m~3000m에 자생하는 고원식물이다. 장홍화는 여성질환예방과 두뇌의 신경안정, 호르몬분비 촉진, 학습증진과 기억력향상에 의한 알츠하이머 치료의 효과가 있는 것으로 알려져 있으며, 함유되어 있는 크로신은 암세포를 파괴시키어 종양세포를 줄이는 작용을 하며, 카로티노이드 성분이 항산화 활성과 면역을 증진시키어 항암효과를 가져다 준다. 또한 다량의 칼륨을 함유하고 있어서 나트륨배출에 효과적이어서 혈압을 떨어뜨리는 작용을 한다. 또한 신경전달물질의 활동을 증진시키어서 스트레스 해소와 치매 및 인지력을 높여준다고도 알려져 있다. 본 실험에서는 장홍화(藏紅花)추출액의 총 폴리페놀 함량과 항산화 물질 활성을 조사했던 바, 장홍화(藏紅花) 메탄올과 에탄올추출액에서 항산화 반응이 매우 양호하였다. 또한 총 폴리페놀 함량도 에탄올 추출물과 메탄올 추출물 처리구에서도 비슷한 결과를 나타내었다. 이러한 결과들로 미루어 볼 때 장홍화(藏紅花)의 추출액은 건강음료와 화장품의 기능성원료로도 이용이 가능할 것으로 추측되었다.

• The Monthly Diabetes
• /
• s.220
• /
• pp.70-73
• /
• 2008

현대 사회는 '스트레스의 사회'라 해도 과언이 아니다. 직장인들은 직장에서, 학생들은 학교에서, 심지어 어린 아이들에서도 스트레스로 인한 각종 질병이 발생하고 있다. 육체적 스트레스에서 심리적, 정신적 스트레스까지 각종 스트레스의 원인들로부터 둘러싸여 살아가고 있는 것이 지금 현대인의 일상이다. 스트레스로 인한 각종 질병들 중에서도 직장인들은 물론, 여성을 비롯해 학생들에게서 많이 발생하고 있는 것 중의 하나가 원형탈모증이다. 최근에는 각종 공해와 유해물질이 많아지면서 남녀 모두에게서 탈모 인구가 증가되었다. 사회는 점점더 복잡해지고 인스턴트식품의 섭취와 환경호르몬이 증가되면서 머리카락도 견디기 힘든 시대가 된 것이다. 일반적인 탈모와는 달리 원형탈모는 일시적인 탈모현상으로 비교적 쉽게 치료가 가능한 탈모증상이라고 알려져 있다. 그러나 대수롭게 넘겼다가는 탈모로 인한 스트레스까지 겪어야 할지도 모를 일이니 이번 기회를 통해 원형탈모에 대해 좀 더 구체적으로 알아보도록 하자.

• Clinical and Experimental Pediatrics
• /
• v.49 no.7
• /
• pp.703-709
• /
• 2006

Since the advent of growth hormone(GH), children with a wide variety of growth disorders have received GH treatment. In GH deficiency(GHD), Turner syndrome, chronic renal failure, children born small for gestational age, Prader-Willi syndrome, and idiopathic short stature, the therapeutic effects and safety profile of GH are reviewed. GH therapy has been clearly shown to improve height velocity and final adult height in a variety of pediatric conditions in which growth is compromised irrespective of GHD. Early initiation and individualization of GH treatment has the potential to normalize childhood growth. The supra-physiological doses of GH have been shown to increase height velocity during childhood and final height in non-GHD conditions. Adverse events during GH therapy are uncommon and often not drug related. However continued surveillance into adult life is crucial, especially in children receiving supra-physiological doses or whose underlying condition increases their risk of adverse effects.

• Proceedings of the Korean Society of Applied Pharmacology
• /
• 1996.11a
• /
• pp.85-89
• /
• 1996

성장저해는 만성신부전 (chronic renal failure, CRF) 소아환자나 실험동물에게서 나타나는 합병증의 하나로, 그 발생기전이 잘 알려져 있지 않다. 성장저해를 일으키는 원인으로 비내분비적 요인 (metabolic acidosis, renal osteodystrophy, anemia)과 내분비적 요인의 복합적 결과로 생각하나, 비내분비적 요인들은 약물투여로 그 증세를 완화시켜도 성장저해에 대한 궁극적 치료효과는 나타나지 않는다. 따라서 성장 호르몬 (Growth Hormone, GH)이 관여하는 내분비적 요인의 변화에 그 병리기전이 있을 것으로 연구되어 왔다. GH는 직접적 성장 효과와 Insulin-like growth factor-1(IGF-I)을 간으로부터 유리시켜 나타나는 간접적 성장효과를 가지고 있다. 그런데 CRF환자의 GH 및 IGF-I 의 혈중 농도는 정상이거나, 흑은 오히려 증가상태에 있음에도 볼구하고 성장저해가 일어나는 것으로 보아, 환자의 말단기관 (end-organ)에 원인을 알 수 없는 저항성 (resistance)이 있다고 규정되어진다.

• Childhood Kidney Diseases
• /
• v.8 no.1
• /
• pp.80-85
• /
• 2004

The systemic lupus erythematosus(SLE) is a systemic inflammatory disease caused by autoimmune mechanism, involving blood cells, the kidney, the central nervous system, and etc. The heart is one of the frequently involved organs but it is rare as an initial manifestation. Therefore, early suspicion and accurate diagnosis followed by aggressive immunosuppressive therapy including corticosteroid is mandatory for heart-involved patients. We experienced a case of pericardial effusion as an initial manifestation of childhood SLE, which showed immediate response to corticosteroid.